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Objective: To examine the potent of water as a solvent agent in the preparation of
traditional herbal medicine.
Methods: Water extracts of 18 plants were prepared through reﬂux and examined
(25 mg/mL) to evaluate their possibility for inhibiting protein tyrosine phosphatase 1B
(PTP1B). The determination of IC50 values was performed for the samples possessing
more than 80% inhibition. Meanwhile, those exhibiting IC50 values more than 7.0 mg/mL
were further proﬁled for their chemical constituents through nuclear magnetic resonance
(NMR) measurement.
Results: About 44% (8) of the examined samples showed more than 80% inhibition
against PTP1B. The water extracts of Elephantopus scaber, Helicteres isora aerial parts,
Elaeocarpus grandiﬂorus (E. grandiﬂorus) fruits, Melaleuca leucadendron leaves, and
Quercus infectoria gum had IC50 values ranging from 2.05 to 6.90 mg/mL. Meanwhile,
Andropogon nardus and Centella asiatica were at the area of d 3.0–4.0 ppm. Further, the
13C NMR observation of samples possessing the most intensive signals in their proton
NMR Cinnamomum burmannii and E. grandiﬂorus showed the peaks at the area of d 60–
90 ppm as the supportive evidence for sugar group signals. Intriguingly, a disaccharide
from E. grandiﬂorus could be an active inhibitor towards PTB1B.
Conclusions: In contrast to the mainstream solvents currently used in modern herbal
manufactures especially Jamu medicine in Indonesia, pure-water-extracted materials
should be reconsidered and could be reemerged for future studies and for the manufacture
of herbal medicines. In addition, the activity of Jamu components should be conﬁrmed
that their antidiabetes and antiobesity activities could be through the inhibition of PTP1B.1. Introduction
Traditional medicines e.g. medicinal plants have been
embedded in human civilization. Indonesian herbal preparation,locally called Jamu medicine, remains popular to date. Its
preparation was originally done by crushing or squeezing or
boiling herbal materials in water. In the past, people and tradi-
tional societies mainly employed water as the extracting solvent
[1]. In this way, water soluble matters became the main
constituent of traditional medicines. In two decades, Jamu has
been formulated and prepared in modern dosage forms. Jamu
industries have also recently been thriving very well. At the
main time, Jamu medicines industries have been thriving very
well in two decades. As revealed by Indonesian Ministry ofopen access article under the CC BY-NC-ND
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Indonesian population is Jamu users [2].
The introduction of organic solvents for herbal extraction and
support of ofﬁcial guiding monographs [3,4], however, has
indirectly encouraged the ethanol usage in industrial ﬁeld as
well as in academic activities. Indeed, this became a hall mark
of an era where a vast majority of registered Jamu products in
the market are prepared from ethanol extract (ethanol 50%–
96%). The supportive advantages of using ethanol are in view
of its fast drying process, less toxic content, and simplicity to
avoid microbial growth in comparison to water. This
phenomenon, as a consequence, has marginalized the water
utility in herbal extraction in the last two decades. Previously,
Jamu was prepared mainly as recenter paratus by infusion or
decoction [5], in which water soluble matters were the main
component. In other words, representing herbal medicines with
organic solvent extracts is most likely not factual and could be
biased from its historical traditions.
To conﬁrm the nature of traditional preparation of herbal
medicines through water solvent extraction, 18 water extracts
referred in traditional formulation records of Jamu components
for antidiabetes or antiobesity: Abrus precatorius L.
(A. precatorius), Acarus calamus L. (A. calamus), Andropogon
nardus L. (A. nardus), Centella asiatica L. (C. asiatica), Cor-
iandrum sativum L. (C. sativum), Elaeocarpus grandiﬂorus
Smith (E. grandiﬂorus), Elephantopus scaber L. (E. scaber),
Helicteres isora L. (H. isora), Imperata cylindrica (L.) P. Beauv
(I. cylindrica), Kaempferia galanga L. (K. galanga), Melaleuca
leudendron L. (M. leudendron), Myristica fragrans (Houtt.)
(M. fragrans), Nigella sativa L. (N. sativa), Pandanus amar-
yllifolius Roxb. (P. amaryllifolius), Parkia roxburghii G. Don.
(P. roxburghii), Phyllanthus niruri L. (P. niruri), Quercus
infectoria (Oliver) (Q. infectoria), and Trigonella foenum-grae-
cum L. (T. foenum-graecum) were submitted for test against
protein tyrosine phosphatase 1B (PTP1B) as a molecular target
model. PTP1B is a validated negative insulin regulator in its main
targeted organs, i.e. lever, kidney, and skin [6–8]. Meanwhile,
excessive PTP1B in brain will impair the signaling of leptin, a
major appetite regulator [9,10]. Here, the samples showing more
than 80% inhibitory activities were further determined for their
IC50 values. To observe chemical constituent groups which
could be possible corresponding for this bioactivity, a chemical
proﬁling was conducted by using proton and carbon nuclear
magnetic resonance [1H/13C nuclear magnetic resonance
(NMR)]. NMR spectrometry is a reliable and comprehensive
method for being able to provide a “holistic view” [11]
compared to the other customized analytical methods such as
liquid or gas chromatography, infrared spectrometry, and mass
spectrometry. The area of diagnostics, i.e. amino acids (d 2–
2.8 ppm), sugars (d 3–4 ppm), and aromatic regions (d 6–
8 ppm) that NMR allows us to speciﬁcally distinguish the
peaks of interest. It is robust, no need for calibration,
indestructible towards analyses, and efﬁciency e.g. 10 min for
data acquisition. In a course of studies for ﬁnding PTP1B
inhibitors, water extract of Blumea balsmifera leaves,
Cinnamomum burmannii (C. burmannii) barks, Syzygium
aromaticum fruits, and Syzygium polyanthum leaves exhibited
some potent activities with IC50 values of 2.68, 6.25, 4.07, and
3.14 mg/mL, respectively [12]. Moreover, they have been
recorded in Jamu formulations for the treatment of diabetes and
obesity as well [13,14]. In this paper, we also report their
chemical constituent proﬁles based on NMR spectra.2. Materials and methods
2.1. Herbal materials
The herbal materials used in this study (Table 1) were pur-
chased from Pasar Genteng Surabaya and authenticated by one
of the authors (Dr. Subehan). The voucher specimens were
preserved in Museum of Materia Medica, Analytical Research
Center for Ethnomedicines, Institute of Natural Medicine, Uni-
versity of Toyama, Toyama, Japan.
2.2. Preparation of test solutions
Each medicinal herb (25–150 g) was cut into small pieces
and extracted with water (150–400 mL, 1-h reﬂux, 100 C, ×2).
After ﬁltration, the water solution was concentrated under a
reduced pressure, followed by lyophilization, to result in a water
extract. All extracts were stored under −80 C before being in
use. For the PTP1B inhibitory assay, the extracts were dissolved
in distilled water at the concentration of 1 mg/mL and aliquots of
the solution were added to each well. The ﬁnal concentration for
each sample was 25 mg/mL.
2.3. PTP1B inhibitory assay
The assay was performed in 96-well clear polystyrene
microplate (Corning, NY, USA) according to Cui et al. with
slight modiﬁcations [21]. Each well contained 0.05 mg PTP1B
(Enzo Life Sciences, Farmingdale, NY), 2 mmol/L p-
nitrophenyl phosphate (pNPP; Wako Pure Chemical Industries,
Osaka, Japan), and 50 mmol/L citrate buffer containing
0.1 mmol/L NaCl, 1 mmol/L dithiothreitol, and 1 mmol/L
ethylenediamine-N,N,N0,N0-tetraacetic acid. The ﬁnal volume
of the mixture was 200 mL. The reaction was initiated by the
addition of pNPP, incubated at 37 C for 30 min, and
terminated with the addition of a stop solution (10 mol/L
NaOH). The amount of p-nitrophenol produced was estimated
by measuring the absorbance at 405 nm using a Perkin-Elmer
HTS 7000 bioassay reader. To identify the level of nonenzy-
matic substrate hydrolysis, the absorbance of wells only con-
taining buffer and pNPP were measured for correction. The
difference between full enzymatic activity and the correction
was set arbitrarily to 100% activity. The percent residual activity
was calculated using the following formula:
Residual activity ð%Þ =
½Absðfull enzymaticÞ−Absðtest sampleÞ −AbsðcorrectionÞ
½Absðfull enzymaticÞ−AbsðcorrectionÞ × 100
where Abs(full enzymatic) was the absorbance of p-nitrophenol
liberated by the enzyme in the system without a test sample in
contrast to Abs(test sample). The assays were performed in
triplicate for all samples. The recognized phosphatase inhibitors,
RK-682 (purity 98%; Enzo Life Sciences) [22] and ursolic acid
(purity 90%; Tokyo Chemical Industry, Tokyo, Japan) [23]
were used as the positive controls.
2.4. Statistical analyses
IC50 values were obtained by calculating the linear regression
using MS Excel. A number of statistical differences were then
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values < 0.05 were considered to be signiﬁcant.
2.5. NMR measurement
NMR spectra were measured using a JEOL JNM-LA400
spectrometer. Chemical shifts were given in the d scale. Sam-
ple for measurement was 15–20 mg and dissolved up to 0.8 mL
with D2O (Cambridge Isotope Lab, UK). The NMR chemical
shifts in the spectra were referenced to 3-(trimethylsilyl) propi-
onic-2,2,3,3-d4 acid at 0.00 ppm. For 1H NMR measurement,
each spectrum consisted of 96 scans of 32768 points. On the
other hand, 13C NMR of Eucalyptus ﬂoribunda and
C. burmannii measurements consisted of 43478 and 28553
scans, respectively.
3. Results
3.1. PTP1B inhibitory activity
Among the extracts listed in Figure 1, A. nardus (85.2%),
C. asiatica aerial parts (83.3%), E. grandiﬂorus fruits (96.4%),
E. scaber leaves (96.4%), H. isora gum (95.9%), Melaleuca leu-
cadendron (M. leucadendron) leaves (96.0%), P. niruri (83.3%),
and Q. infectoria (94.7%) exhibited more than 80% inhibition at
the concentration of 25 mg/mL. Meanwhile, the positive controls
RK-682 and ursolic acid exhibited 98.8% inhibition.
In contrast, P. roxburghii (65.4%) extract showed a moderate
activity. The extracts of A. precatorius (6.6%), A. calamus
(21.6%), C. sativum (12.1%), I. cylindrical (18.1%), and
P. amaryllifolius (17.6%), meanwhile, exhibited mild activities
(2.3%–21%). Their tested solutions formed darker color pro-
ducing higher absorbance values compared to the blank solutions,
K. galanga, N. sativa and T. foenum-graecum seed that showed
minus inhibitions, ranging from −14.2% to −0.6%. However, the
negative values were justiﬁed as the inactive samples. This in-
dicates that the activity mechanisms of these recorded compo-
nents, both as antidiabetes and as obesity remedies, might be
performed through other molecular targets or pathways.Table 1
Indonesian medicinal plants, used part and usage or indication.
Species Family Voucher Used part Re
A. precatorius Fabaceae 24925 Leaves An
A. calamus Acaroceae 24923 Roots An
A. nardus Poaceae 24905 Leaves An
C. asiatica Apiaceae 24919 Aerial parts An
C. sativum Apiaceae 24901 Fruits An
E. grandiﬂorus Alaeocarpaceae 24916 Fruits An
E. scaber Asteraceae 24931 Aerial parts An
H. isora Malvaceae 24922 Gum An
I. cylindrica Poaceae 24918 All parts An
K. galanga Zingiberaceae 24905 Rhizomes An
M. leudendron Myrtaceae 24917 Leaves An
M. fragrans Myrtaceae 24904 Seeds An
N. sativa Ranunculaceae 24902 Seeds An
P. amaryllifolius Pandanaceae 24911 Aerial parts Di
P. roxburghii Fabaceae 24929 Seeds An
P. niruri Euphorbiaceae 24930 Aerial parts An
Q. infectoria Fagaceae 24924 Fruits An
T. foenum-graecum Fabaceae 24914 Seeds AnFurther IC50 examination of the samples showing more than
80% inhibitions, they demonstrated a dose dependent inhibitions
with IC50 values ranging from 2.05 to 13.20 mg/mL (Table 2). In
particular, M. leucadendron was the most potent sample
demonstrating the IC50 value equal to that of the positive control
RK-682 (2.05 mg/mL) and more potent compared to ursolic acid
(IC50 = 9.11 mg/mL). Interestingly, those potent samples were
made up 44% of examined samples. Hence, their traditionally
reported antidiabetes and obesity activity could be due to PTP1B
inhibition.
3.2. Analyses of chemical composition of water extract
To observe the chemical constituents that could be possible
to be a corresponding constituent to inhibitory activity, NMR
measurement was conducted towards those potent samples. The
area of diagnostics i.e. amino acids, sugars, vinyl, and aromatic
chemical shift zones, both 1H and 13C NMR spectra that allowed
us to speciﬁcally distinguish the peaks of interest. According 1H
NMR spectra, those extracts exhibited some dominant peaks
ranging from d 3–4.2 ppm (Figure 2).
Therefore, most of active samples showed the peaks of
oxygenated methylene protons called as sugar zone. Although
Blumea balsamifera and H. isora spectra showed some aliphatic
signals at d 1.2–2.6 ppm and vinyl peak signals at d 6–7 ppm
which were attributable as aliphatic and aromatic of amino acid
signals, these peaks exhibited several short intensities which
could be present in low quantity. For this reason, sugars must be
present in much higher concentration in all active samples and
contributed signiﬁcantly to their activity. Meanwhile, E. scaber,
A. nardus, and M. dendron extracts had some comparable in-
tensities in both sugar and amino acid peak signals (d 1.2–
2.5 ppm) (Figure 2b, c and f). In an aqueous extract, sugars were
found usually including fructose, sucrose, and glucose. Differ-
ently, amino acids frequently present are arginine, alanine,
glutamate, serine, glutamine, asparagine, histidine, proline, and
valine. The available organic acids included malic, ascorbic,
citric, and succinic acid [24].
Considering our experiences that sugars normally have a low
signal intensity in 13C NMR measurements, we then chosecorded usage or indication Reference Extraction
yield (%)
tidiabetes [14] 9.5
tidiabetes [15] 14.5
tidiabetes and antiobesity [13] 6.4
tidiabetes [14] 22.0
tiobesity and hyperlipidemia [14] 7.6
tidiabetes [16] 3.3
tiobesity and hyperlipidemia [13] 16.7
tidiabetes [17] 10.2
tiobesity and hyperlipidemia [14] 7.5
tidiabetes, antiobesity and hyperlipidemia [13,14] 6.7
tiobesity and hyperlipidemia [13] 3.4
tiobesity and hyperlipidemia [13,18] 9.3
tihiperlidemia [19] 13.6
abetes mellitus [18] 3.9
tiobesity and hyperlipidemia [13] 11.2
tiobesity and hyperlipidemia [13] 14.1
tiobesity and hyperlipidemia [13] 59.1
tidiabetes [20] 1.7
Table 2
Samples with  80% inhibition and their IC50 values.
Samples IC50 (mg/mL)
A. nardus 10.63
C. asiatica 13.20
E. grandiﬂorus 6.90
E. scaber 2.64
H. isora 3.49
M. leucadendron 2.05
P. niruri 10.99
Q. infectoria 4.68
RK 682 2.05
Ursolic acid 9.11
Figure 2. The representative 1H NMR spectra of several water plant extracts.
1H NMR spectrum of a: A. nardus; b: E. scaber; c: P. niruri; d: Syzygium aroma
h: Syzygium polyanthum leaves. All samples showed sugar proton signals at d
amino acid signals at d 1.5–2.5 ppm. Internal standard (3-(trimethylsilyl) propi
Figure 1. PTP1B residual activity due to the effect of water extract of Indonesian medicinal plants at a concentration of 25 mg/mL.
RK-862 and ursolic acid were used as the positive controls. Residuals higher than 100% were related to a darker tested solution resulted by three samples.
Data points represent mean ± SEM; n = 3. A: RK-862; B: Ursolic acid; C: A. precatorius; D: A. calamus; E: A. nardus; F: C. asiatica; G: C. sativum; H:
E. grandiﬂorus; I: E. scaber; J: H. isora; K: L. cylindrica; L: K. galanga; M: M. leudendron; N: M. fragrans; O: N. sativa; P: P. amaryllifolius; Q:
P. roxburghii; R: P. niruri; S: Q. infectoria; T: T. foenum-graecum.
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1H NMR spectra to measure. Their spectra conﬁrmed the pres-
ence of sugar carbon signals at d 60–90 ppm. Although 13C
NMR of C. burmannii showed three peaks between d 90–
105 ppm and two short peaks at d 145 and 152 ppm, respec-
tively, these peaks should be the part of sugar structures
(Figure 3). Interestingly, 1H and 13C NMR spectrum of
E. grandiﬂorus clearly revealed eleven carbon signals at d 60.1,
62.9, 63.2, 64.2, 64.7, 70.0, 71.8, 73.2, 73.4, 74.8, 77.2, 82.2,
and 104.2 ppm (Figure 3d), which were similar to those of su-
crose [25]. Moreover, its 1H NMR signal at d 5.2 ppm (Figure 3c,
arrow) also showed a good agreement [11,24].ticum; e: Blumea balsamifera leaves; f: H. isora fruits; g: M. leucadendron;
3.0–4.5 ppm. It was only E. scaber that showed a comparable intensity of
onic-2,2,3,3-d4 acid).
Figure 3. The representative NMR spectra of water extracts of C. burmannii and E. grandiﬂorus.
a and b: 1H and 13C NMR spectra of C. burmannii leaves; c and d: 1H and 13C NMR spectra of E. grandiﬂorus fruits.
Azis Saifudin et al./Asian Pac J Trop Biomed 2016; 6(1): 38–4342Therefore, on the basis of both NMR spectra the compound
was deduced as a disaccharide which could be a succrose. The
sugar remarkably showed 95% purity according to this 1D NMR
analyses. Hence, this simple sugar should be the main contrib-
utor towards its extract activity. However, this case should not
be taken into account for in vivo case immediately.4. Discussion
This study was embarked from a very simple hypothesis that
water extracts contain a group of polar compounds rather than
secondary metabolites. Thus, based on the fact, traditional
preparation have been relaying on water extraction. The water
extracts of all 18 samples of Indonesian medicinal plants
recorded in Jamu formulations or reported as antidiabetes or
antiobesity were examined for their ability to inhibit PTP1B-
mediated dephosphorylation of pNPP. Based on NMR ana-
lyses, it is convincing that instead of secondary metabolites, the
activity of original Jamu medicines is due to the signiﬁcant
contribution of sugars or synergism or plausible effect among
sugars, amino acids, and organic acids. Hence, water extracted
herbal medicine has a distinguished paradigm and secondary
metabolite based on Jamu medicine is another paradigm.
To date, the reports on the activities of carbohydrate class on
antidiabetes related target via the inhibitory of PTP1B are still
limited. It is just recently reported that saccharide from Astra-
galus membranaceus inhibits PTP1B and decreases PTP1B
expression via relieving endoplasmic reticulum stress [26].
Saccharides from Morus alba leaves exhibited the hepatic
glucose metabolism and insulin signaling by inhibiting the
expression of PTP1B [27]. Acidic proteoglycan from fungi
Ganoderma lucidum shows the competitively inhibiting PTP1B
[28,29]. However, rather than saccharides, micromolecules have
been becoming an interest in hitherto PTP1B inhibitor
discoveries [30–32]. Thus, carbohydrates could also be a
promising candidate to explore in future studies. Previously, we
demonstrated the pairs of organic and water extracts in total of
56 extracts [12]. Of these extracts, 9 water extracts and 11
methanol extracts showed more than 70% inhibition with IC50
values ranging from 2.05 to 13.4 mg/mL. From the methanol
extract, we isolated the active secondary metabolite type
comprising sequiterpens, triterpenes, and phloroglucinols.
Hence, in our current study, the water extracts activity was
contributed signiﬁcantly by sugars and polar matters.
Unfortunately, the use of pure water as a solvent is almost
absent in the ofﬁcial guidances for industrial scale issued byIndonesian Drug and Food Control Agency [33]. Therefore, to
some extent it should be revised based on Jamu historical
preparations.
On the basis of the ﬁndings, water soluble extracts should not
be ignored from utilities. It can be noted here that the paradigm
of representing traditional medicine preparations with organic
solvents seem to be inappropriate. For modern herbal manu-
facturers, reintroducing water as an extracting solvent should be
considered. Although prepared in organic or water solvent, Jamu
medicine must be simultaneously and scientiﬁcally conﬁrmed
regarding their pharmacological effect and chemical constitu-
ents. Finally, it is worth noting that the results of 44% those
potent water extracts should also conﬁrm the possibility of
recorded Jamu components for antidiabetes and obesity through
the inhibition of PTP1B activity.
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